Hsiu-Ting Lin

537 total citations
13 papers, 249 citations indexed

About

Hsiu-Ting Lin is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Hsiu-Ting Lin has authored 13 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Hsiu-Ting Lin's work include SARS-CoV-2 and COVID-19 Research (9 papers), Viral gastroenteritis research and epidemiology (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Hsiu-Ting Lin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), Viral gastroenteritis research and epidemiology (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Hsiu-Ting Lin collaborates with scholars based in Taiwan. Hsiu-Ting Lin's co-authors include Han‐Chung Wu, Chen Wy, Kang-Hao Liang, Yuan‐Chih Chang, Tzu‐Jing Yang, Meng‐Ru Ho, Shang‐Te Danny Hsu, Pei‐Yu Yu, Dan‐Jae Lin and Walter Chang and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Nature Structural & Molecular Biology.

In The Last Decade

Hsiu-Ting Lin

13 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hsiu-Ting Lin Taiwan	8	161	93	39	36	32	13	249
Daniel Poston United States	7	343 2.1×	183 2.0×	58 1.5×	22 0.6×	51 1.6×	8	450
Noemi Manganaro Italy	8	336 2.1×	124 1.3×	38 1.0×	18 0.5×	51 1.6×	9	413
Kieu Lam Canada	6	92 0.6×	290 3.1×	15 0.4×	17 0.5×	42 1.3×	9	365
Michael C. McGee United States	8	151 0.9×	148 1.6×	13 0.3×	13 0.4×	25 0.8×	11	347
Lawrence G. Welch United Kingdom	4	240 1.5×	139 1.5×	12 0.3×	13 0.4×	54 1.7×	6	392
Zhengyun Xiao China	6	181 1.1×	168 1.8×	167 4.3×	64 1.8×	41 1.3×	8	392
Eoin Leen United Kingdom	8	94 0.6×	95 1.0×	13 0.3×	8 0.2×	49 1.5×	13	250
Naijing Hu China	7	108 0.7×	323 3.5×	13 0.3×	26 0.7×	19 0.6×	16	451
Jalees A. Nasir Canada	5	110 0.7×	51 0.5×	9 0.2×	20 0.6×	15 0.5×	5	180
Devin Kenney United States	8	199 1.2×	144 1.5×	9 0.2×	11 0.3×	32 1.0×	16	424

Countries citing papers authored by Hsiu-Ting Lin

Since Specialization

Citations

This map shows the geographic impact of Hsiu-Ting Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiu-Ting Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiu-Ting Lin more than expected).

Fields of papers citing papers by Hsiu-Ting Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiu-Ting Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiu-Ting Lin. The network helps show where Hsiu-Ting Lin may publish in the future.

Co-authorship network of co-authors of Hsiu-Ting Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiu-Ting Lin. A scholar is included among the top collaborators of Hsiu-Ting Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiu-Ting Lin. Hsiu-Ting Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kumari, Monika, Shih-Chieh Su, Hsiu-Ting Lin, et al.. (2025). Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residue. Vaccine. 57. 127216–127216. 1 indexed citations

Kumari, Monika, Kang-Hao Liang, Shih-Chieh Su, et al.. (2024). Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern. Vaccines. 12(7). 714–714. 3 indexed citations

Kumari, Monika, Shih-Chieh Su, Kang-Hao Liang, et al.. (2023). Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern. Journal of Biomedical Science. 30(1). 46–46. 5 indexed citations

Lu, Ruei‐Min, Kang-Hao Liang, Hsiao-Ling Chiang, et al.. (2023). Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice. Heliyon. 9(5). e15587–e15587. 4 indexed citations

Hsu, Fu‐Fei, Kang-Hao Liang, Monika Kumari, et al.. (2022). An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization. International Journal of Pharmaceutics. 627. 122256–122256. 18 indexed citations

Ko, Shih-Han, Chen Wy, Shih-Chieh Su, et al.. (2022). Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants. Journal of Biomedical Science. 29(1). 108–108. 7 indexed citations

Shen, Chia‐Ning, Jeng‐Kai Jiang, Cathy S.J. Fann, et al.. (2022). Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients. Frontiers in Oncology. 12. 883437–883437. 18 indexed citations

Lu, Ruei‐Min, Shih-Han Ko, Chen Wy, et al.. (2021). Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19. International Journal of Molecular Sciences. 22(22). 12412–12412. 18 indexed citations

Liang, Kang-Hao, Shih-Han Ko, Yu‐Chi Chou, et al.. (2021). Antibody cocktail effective against variants of SARS-CoV-2. Journal of Biomedical Science. 28(1). 80–80. 17 indexed citations

10.

Liu, I-Ju, Hsiu-Ting Lin, Mei-Jung Wang, et al.. (2021). Identification of COVID-19 B-cell epitopes with phage-displayed peptide library. Journal of Biomedical Science. 28(1). 43–43. 18 indexed citations

11.

Yang, Tzu‐Jing, Pei‐Yu Yu, Yuan‐Chih Chang, et al.. (2021). Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Nature Structural & Molecular Biology. 28(9). 731–739. 103 indexed citations

12.

Chang, Chen, et al.. (2016). Functional assessment of glioma pathogenesis by in vivo multi-parametric magnetic resonance imaging and in vitro analyses. Scientific Reports. 6(1). 26050–26050. 9 indexed citations

13.

Tsai, Ming-Tzu, Dan‐Jae Lin, Sherry Huang, Hsiu-Ting Lin, & Walter Chang. (2011). Osteogenic differentiation is synergistically influenced by osteoinductive treatment and direct cell–cell contact between murine osteoblasts and mesenchymal stem cells. International Orthopaedics. 36(1). 199–205. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact